HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-selenium-bridged beta-cyclodextrin

has antioxidant activity; structure in first source

Also Known As:

2-SeCD

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ding, Zhiying: 1 article (08/2011)
2.	Li, Nan: 1 article (08/2011)
3.	Lin, Tingting: 1 article (08/2011)
4.	Liu, Junqiu: 1 article (08/2011)
5.	Luo, Guimin: 1 article (08/2011)
6.	Shen, Jiacong: 1 article (08/2011)
7.	Xu, Jiayun: 1 article (08/2011)
8.	Li, Xin-Yang: 1 article (11/2009)
9.	Lin, Ting-Ting: 1 article (11/2009)
10.	Liu, Jun-Qiu: 1 article (11/2009)

Related Diseases

1.	Ischemia 11/01/2009 - "The aim of this study was to investigate the possible effects and mechanism of a new synthesized glutathione peroxidase (GPX) mimic, 2-selenium-bridged beta-cyclodextrin (2-SeCD), on rat liver ischemia-reperfusion (I/R) injury. "
2.	Reperfusion Injury 11/01/2009 - "An insight into the protection of rat liver against ischemia/reperfusion injury by 2-selenium-bridged beta-cyclodextrin."
3.	Neoplasms (Cancer) 08/01/2011 - "In vitro, 2-SeCD reduces the viability of cancer cells by inducing cell cycle arrest in G(2)/M phase. "
4.	Breast Neoplasms (Breast Cancer) 08/01/2011 - "Overall, 2-SeCD sensitises resistant breast cancer cells to TRAIL-based apoptosis in vitro and in vivo. "

Related Drugs and Biologics

1.	Glutathione Peroxidase